Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Quipt Home Medical Corp T.QIPT

Alternate Symbol(s):  QIPT

Quipt Home Medical Corp. is a home medical equipment provider. The Company specializes in improving the home management of chronic illness through the application of telehealth systems and automated distribution. It provides in-home monitoring and disease management services, including end-to-end respiratory solutions for patients in the United States. It offers nebulizers, oxygen concentrators... see more

Recent & Breaking News (TSX:QIPT)

PharmaMar is Present at the 16th International Gynecologic Cancer Society Meeting With New Evidence on Yondelis®

PR Newswire Europe Non Regulatory October 31, 2016

The EMA Accepts to Assess the Marketing Authorization Application from PharmaMar for Aplidin®

PR Newswire Europe Non Regulatory October 28, 2016

PharmaMar Completes the Patient Recruitment for the "CORAIL" Phase III Pivotal Study With PM1183

PR Newswire October 18, 2016

PharmaMar Announces Positive Results From its Phase II Study With lurbinectedin in BRCA 1/2 - Associated Metastatic Breast Cancer at the ESMO 2016 Congress

PR Newswire October 10, 2016

PharmaMar Announces Positive Results From its Phase II Study With lurbinectedin in BRCA 1/2 - Associated Metastatic Breast Cancer at the ESMO 2016 Congress

PR Newswire Europe Non Regulatory October 10, 2016

PharmaMar and Boryung Pharm Sign a Licensing Agreement for Aplidin® (plitidepsin) in Korea

PR Newswire October 4, 2016

PharmaMar Submits MAA to EMA for Aplidin® for the Treatment of Multiple Myeloma

PR Newswire September 22, 2016

PharmaMar Submits MAA to EMA for Aplidin® for the Treatment of Multiple Myeloma

PR Newswire Europe Non Regulatory September 22, 2016

IIROC Trading Resumption - PHM, PHM.DB

Canada NewsWire September 20, 2016

PHM Proposes Separation Into Two New Industry-Leading Public Companies

MarketWire Canada September 20, 2016

IIROC Trading Halt - PHM

Canada NewsWire September 20, 2016

Patient Home Monitoring Releases Conference Call Highlighting Financial Q3 FY 2016

MarketWire Canada August 26, 2016

Patient Home Monitoring Posts Third Quarter Financials and Updates Ongoing Integration Activities

MarketWire Canada August 24, 2016

Patient Home Monitoring Announces Date and Time for Quarterly Conference Call

MarketWire Canada August 22, 2016

Patient Home Monitoring Announces Appointment of New Chief Financial Officer; Overhead Reduction and Staff Realignment; Updates Regulatory BAR Requirement

MarketWire Canada June 29, 2016

PHM Announces Chief Operating Officer Greg Crawford Added to the Board of Directors of PHM Services Inc.

MarketWire Canada June 10, 2016

Patient Home Monitoring Releases Conference Call Highlighting Financial Results From Q2 FY 2016

MarketWire Canada May 27, 2016

Patient Home Monitoring Posts Second Quarter Financials; Announces Integration and Reimbursement Cut Restructuring Plan on Target

MarketWire Canada May 26, 2016

Patient Home Monitoring Announces Date and Time for Quarterly Conference Call

MarketWire Canada May 25, 2016

Patient Home Monitoring Clarifies Regulatory BAR Requirement

Marketwired April 26, 2016